An investigation for investors in Aoxing Pharmaceutical Company Inc (NYSEMKT:AXN) shares over potential securities laws violations by Aoxing Pharmaceutical Company was announced and NYSEMKT:AXN stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 01/13/2016 -- An investigation for shareholders in Aoxing Pharmaceutical Company Inc (NYSEMKT:AXN) over potential securities laws violations by Aoxing Pharmaceutical Company and certain of its directors and officers was announced.
Investors who purchased shares of Aoxing Pharmaceutical Company Inc (NYSEMKT:AXN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Aoxing Pharmaceutical Company regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On December 1, 2015, post-market, Aoxing Pharmaceutical Company Inc reported the resignation of Wilfred Chow, the Company's Chief Financial Officer, on November 30, 2015.
Shares of Aoxing Pharmaceutical Company Inc (NYSEMKT:AXN) declined to as low as $0.98 per share on December 3, 2015, respectively $0.60 per share on January 4, 2016.
Those who purchased shares of Aoxing Pharmaceutical Company Inc (NYSEMKT:AXN) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com